Skip to main content
. 2018 Jul 25;7(9):4825–4835. doi: 10.1002/cam4.1698

Table 1.

Breast cancer and treatment characteristics of the 96 breast cancer patients by radiation‐associated sarcoma

Characteristic Total no. of patients, n (%) Angiosarcoma, n (%) Other sarcoma, n (%) P a
96 50 46
Surgery type
Mastectomy 44 (46) 11 (22) 33 (72) <0.05
Resection 52 (54) 39 (78) 13 (28)
Primary BC tumor size
<20 mm 53 (55) 34 (68) 19 (41) 0.127
≥20 mm 26 (27) 12 (24) 14 (30)
Missing 17 (18) 4 (8) 13 (28)
Histology
Ductal 61 (64) 35 (70) 26 (57) <0.05
Lobular 14 (15) 10 (20) 4 (9)
Other 15 (16) 4 (8) 11 (24)
Missing 6 (6) 1 (2) 5 (11)
Grade
1 19 (20) 16 (32) 3 (7) <0.05
2 41 (43) 26 (52) 15 (33)
3 9 (9) 2 (4) 7 (15)
Missing 27 (28) 6 (12) 21 (46)
Node status
Negative 53 (55) 34 (68) 19 (41) <0.05
Positive 42 (44) 16 (32) 26 (57)
Missing 1 (1) 0 1 (2)
Estrogen receptor status
Negative 8 (8) 3 (6) 5 (11) 0.439
Positive 57 (59) 38 (76) 19 (41)
Missing 31 (32) 9 (18) 22 (48)
Progesterone receptor status
Negative 17 (18) 12 (24) 5 (11) 0.316
Positive 46 (48) 29 (58) 17 (37)
Missing 33 (34) 9 (18) 24 (52)
HER2 overexpression
Negative 31 (32) 20 (40) 11 (24) 1.00
Positive 2 (2) 1 (2) 1 (2)
Missing 63 (66) 29 (58) 34 (74)
Adjuvant endocrine therapy
No 63 (66) 32 (64) 31 (67) 0.840
Yes 33 (34) 18 (36) 15 (33)
Adjuvant chemotherapy
No 76 (79) 48 (96) 28 (61) <0.05
Yes 20 (21) 2 (4) 18 (39)
Axillary lymph node RT
No 49 (51) 37 (74) 12 (26) <0.05
Yes 46 (48) 13 (26) 33 (72)
Missing 1 (1) 0 1 (2)
Radiation boost at tumor bed
No 79 (82) 37 (74) 42 (91) <0.05
Yes 17 (18) 13 (26) 4 (9)

HER2, human epidermal receptor 2; RT, radiation therapy.

a

Either chi‐squared or Fisher's exact test.